Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Clinical trial NCT05898828 · WITHDRAWN

Trial details

NCT number: NCT05898828
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms Esophageal Neoplasms Esophagus Neoplasm Esophagus Cancer Neoplasms, Esophageal Esophageal Cancer (EsC)

Start date: 2024-08-02
Primary completion: 2024-08-02
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.